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Abstract
The role of DNA methylation patterns in complex phenotypes remains unclear. To explore
this question, we adapted our methods for rare variant analysis to characterize genome-
wide murine DNA hybridization array to investigate methylation at CpG islands, shores, and
regulatory elements. We have applied this platform to compare age and tissue- specific
methylation differences in the brain and spleen of young and aged mice. As expected from
prior studies, there are clear global differences in organ-specific, but not age-specific, meth-
ylation due mostly to changes at repetitive elements. Surprisingly, out of 200,000 loci there
were only 946 differentially methylated cytosines (DMCs) between young and old samples
(529 hypermethylated, 417 hypomethylated in aged mice) compared to thousands of tissue-
specific DMCs. Hypermethylated loci were clustered around the promoter region of Sfi1,
exon 2 of Slc11a2, Drg1, Esr1 and Foxa2 transcription factor binding sites. In particular,
there were 75 hypermethylated Foxa2 binding sites across a 2.7 Mb region of chromosome
11. Hypomethylated loci were clustered around Mid1, Isoc2b and genome-wide loci with
binding sites for Foxa2 and Esr1, which are known to play important roles in development
and aging. These data suggest discreet tissue-independent methylation changes associ-
ated with aging processes such as cell division (Sfi1, Mid1), energy production (Drg1,
Isoc2b) and cell death (Foxa2, Esr1).
Introduction
Aberrations in the processes that regulate healthy aging result in a wide array of disease and
disability. However, the molecular, genetic and epigenetic regulation of these processes is only
moderately understood. Epigenetic modifications (including DNA methylation) are heritable
but potentially reversible and may change throughout life. Methylation of cytosine residues
represents an important epigenetic mechanism that typically acts to repress gene transcription.
The link between aging and DNA methylation levels has been extensively studied, and recent
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studies have looked at analyzing methylation as a proxy for the aging process as a whole[1,2].
DNA methylation can be affected by different factors such as environment, lifestyle, diet and
toxin exposure[3,4], and has been shown to play an important role in complex disease such as
cancer[5–9], metabolic disorders [10,11], neurological diseases[12–14], cardiovascular dis-
eases[15,16] and myopathies[17,18]. Further, changes in DNA methylation have been shown
to play a role in learning, memory, and aging-associated cognitive decline[19–22].
Previously, global levels of DNA methylation have been shown to decrease with aging[7,23–
25]. However, most studies used relatively low resolution array-based platforms that mainly
focus on CpG islands and repetitive elements, neglecting other regulatory elements in the
genome[24–26]. Because of this, the overall loss of methylation is attributed to non-functional
LINE and Alu sequences, rather than functional genomic regions[27,28]. To the contrary, sev-
eral studies have demonstrated age-specific hypermethylation at bivalent chromatin domains
[29,30] containing developmental and regulatory loci[31] such as the polycomb repressor
complex[32], estrogen receptors[33–35], IGF2[36] and many others.
In order to characterize age-specific, genome-wide DNA methylation changes outside of
CpG islands and repetitive elements, we employed a targeted, genome-wide murine methy-
lome capture array followed by a high-throughput bioinformatic workflow to efficiently and
accurately survey discreet variations in DNA methylation. As proof of principal, we focused
on comparisons between brain and spleen methylation in juvenile (1–2 month) and aged (>20
months) mice. The rationale was that brain tissues have low levels of cell division and environ-
mental exposure due to the blood-brain barrier compared to the highly replicating tissues of
the reticuloendothelial system and their exposure to anything in the bloodstream.
Materials and methods
Designing the RNA hybridization “bait” library
The Agilent SurePrint oligo manufacturing and SureSelect hybridization target enrichment
technology uses biotinylated 120 base pair RNA “baits” to selectively hybridize with comple-
mentary sequences in a sample of randomly fragmented source DNA. In collaboration with
Agilent, we designed a murine-specific DNA methylation hybridization array that targets up
to 84 Mb of CpG islands, shores, shelves and regulatory elements in the mouse genome based
on criteria described below. Using databases from the National Center for Biotechnology
Information (NCBI-NIH) (http://www.ncbi.nlm.nih.gov), the University of California Santa
Cruz (UCSC) Genome Browser (http://genome.ucsc.edu) and Ensembl (European Bioinfor-
matics Institute/Wellcome Trust Sanger Institute; http://www.ensembl.org), we obtained the
genomic coordinates for all known CpG islands, shores and shelves in the mouse genome
(mm9). Additionally, we included tissue-specific differentially methylated regions (DMR)[37],
DNase I hypersensitive sites, and different regulatory elements such as promoters, enhancers
and transcription factor binding sites (S1 Table). The combined total mouse methylome
design included ~201,788 targets and ~110Mb of bases covered (due to some overlap between
target regions and regions of systematically poor hybridization, the final region covered is
~85-90Mb). The on-target enrichment for each sample at each of the categories included in
the target design is found in the Supporting Information (S2 Table). This product is commer-
cially available from Agilent (catalog number 931052) and has been used to identify methyla-
tion patterns associated with murine neurodevelopment [38].
Mice
Harvested brains and spleens from three juvenile (1–2 months) and three aged (>20 months)
C57/BL6 mice were kindly provided by Dr. James DiGregori at the University of Colorado—
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Denver. All three biological replicates were prepared and sequenced independently for the
methyl-seq experiments described.
DNA extraction
Extraction of DNA was performed using Qiagen DNeasy Blood & Tissue extraction kit (cata-
log number 69504) as described in the manufacturer’s protocol. The DNA yield from the
extraction resulted in a range from 7–15μg per sample and was quantified using Molecular
Probes fluorescent SYBR Gold (catalog number S11494) assay as previously described by Dru-
ley et al [39].
Methyl-seq library preparation and bisulfite treatment
Methyl-Seq libraries were prepared using Agilent SureSelectXT Mouse Methyl-Seq (catalog
number 931052) and SureSelectXT Reagent Kit, HSQ (catalog number G9611A) as described
in the manufacturer’s protocol. Hybridization, recovery and enrichment were done according
to protocol Version A, August 2012 with no modifications. A total of 3μg of DNA was used for
the library preparation. Following hybridization capture, bisulfite treatment converted
unmethylated cytosines to uracils using the Zymo Research, Zymo EZ DNA Methylation-
Gold (catalog number D5005) kit following manufacturer’s protocol.
Sequencing
Next-generation sequencing was performed in the Edison Family Center for Genome Sciences
and Systems Biology at Washington University using the Illumina HiSeq 2500 platform gener-
ating 101bp paired-end reads, a total of 3 samples were multiplexed for each sequencing lane
generating approximately 90–100 million reads per sample (S2 Table).
Data analysis and bioinformatics
Sequence data was visualized on the Washington University Epigenome Browser (http://
epigenomegateway.wustl.edu/) via a methylC track that displays read depth and methylation
score for every locus of interest across the genome. The Bismark-generated SAM files for
each sample were converted to BAM files using the Samtools view function. The resulting
BAM files were then sorted and indexed using Samtools. The methylation extractor included
as part of the Bismark suite was used to generate a bedGraph file that included data on
methylation percentage and read depth for all cytosines in a CpG context, using the options
-p—comprehensive—bedGraph—zero_based. The methylation score and read depth
at each locus were separated and written into their own files, resulting in two bedGraph files
for each sample: one that contained the methylation score at each locus, and another that con-
tained the corresponding read depth at that locus. The Bismark methylation extractor was also
used to generate a M-bias plot for each sample. The bedGraph files were then zipped via bgzip
and then indexed via tabix. The files were uploaded to a web server and submitted on the Epi-
genome Browser to allow for data visualization.
The R package “methylkit” was used to determine DMCs. The Bismark-generated SAM
files were sorted by chromosome position and read into methylKit using the ‘process
BismarkAln’ function in order to create methylKit-compatible call files for each sample.
Using the ‘getMethylationStats’ function, a histogram for percent methylation distri-
bution was obtained for each sample. Using the ‘filterByCoverage'function, the sam-
ples were filtered by read coverage, discarding bases that had less than 5x read coverage. Each
sample was then tagged with a treatment condition based on both age (young vs. aged) and
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tissue type (brain vs. spleen). Samples were then clustered using the ‘clusterSamples’
function, which hierarchically clusters samples together based on the similarity of their meth-
ylation profiles and draws a dendrogram illustrating this similarity. A PCA Analysis was then
performed on the samples using the ‘PCASamples’ function, which uses the R function
‘prcomp’ to perform a principal components analysis on the samples using percent methyla-
tion matrix as an input. Using the ‘calculateDiffMeth’ function, DMCs were then
obtained for the following comparisons: young brain vs. old brain, young spleen vs. old spleen,
young brain vs. young spleen, old brain vs. old spleen, young vs. old independent of tissue
type, and brain vs. spleen independent of age. These DMCs were obtained by assigning each
sample to a particular treatment condition and then comparing two different treatment condi-
tions using the ‘calculateDiffMeth’ function, which uses logistic regression to calculate
q-values for differential methylation between two treatment types. For example, in order to
determine age-specific DMCs independent of tissue type, the three young spleen samples
and three young brain samples were pooled together by being given the same treatment condi-
tion: “young”. The three old brain and three old spleen samples were also given their own
treatment condition (“old”), and the DMCs between these two treatment conditions were
located by ‘calculateDiffMeth’. After the calculation of q-values and methylation levels
by ‘calculateDiffMeth’, the DMCs were then filtered based on methylation score differ-
ence between treatments and q-value using the ‘getMethylDiff’ function. Only bases that
had a q-value <0.05 and methylation difference >25% between the two treatment conditions
were selected.
In order to annotate these filtered DMCs, BED files containing annotation data for RefSeq
genes, CpG locations and ORegAnno data for the mm9 genome were downloaded from the
UCSC Genome Browser. The DMCs for each comparison were then annotated in methylKit
using the ‘annotateWithGenicParts’ and ‘annotateWithFeatureFlank’func-
tions, which use downloaded annotation data to specifically mark up DMCs. Pie graphs indi-
cating the percentage of bases that overlapped with genic features (promoter, exon, intron,
and intergenic) and CpG features (in shores, shelves or other) were obtained for each compari-
son using the ‘plotTargetAnnotation’ function. In order to better visualize the age-spe-
cific and tissue-independent DMCs, the DMC locations obtained using ‘methylKit’ were used
to guide localization of these same regions on the Epigenome Browser, where they could be
visually interpreted to supplement our quantitative interpretation. DMCs that overlapped sig-
nificantly with important genic and regulatory features could then be properly visualized and
quantitated. All sequencing data generated and analyzed in this study are available at the NCBI
Sequence Read Archive as follows: young brain at SAMN09911432, young spleen at
SAMN09911433, aged brain at SAMN09911434, aged spleen at SAMN09911435.
Reduced representation bisulfite sequencing
Validation of called DMCs was performed using the reduce representation bisulfite sequenc-
ing (RRBS) pipeline as described by Schillebeeckx et al [40]. Briefly, sequencing reads were
aligned to the mouse genome (build mm9/ NCBI37) reference using RRBSMAP[41] filtering
against reads that contain adapter sequence. Reads that showed less than 90% bisulfite conver-
sion (~1 unconverted non-CpG cytosine per read) were filtered to remove those that resulted
from incomplete bisulfite converted molecules. Aligned reads with a mapping quality of zero
were also discarded. The resulting high quality uniquely mapped reads were used for methyla-
tion calling. Genomic coordinates of all CpGs in the reference sequence were identified and
assessed percent DNA methylation by calculating the fraction of reads that had an uncon-
verted cytosine at the CpG position relative to the total reads. Each read requires to have either
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a “TG” or “CG” dinucleotide at the expected CpG coordinate to be considered for analysis.
DMCs were determined using a Fisher’s Exact Test comparing the ratio of methylated versus
unmethylated reads for each sample. CpGs were considered hypomethylated or hypermethy-
lated if they showed a statistically significant decrease or increase of at least 25% [40],
respectively.
Results
Target capture and bioinformatic metrics
After analyzing 90-100M reads per sample, we found ~81.5% of raw reads align to target and
~85% are on-target. For each sample, ~90% [~90 Mb] of the targeted methylome was captured
and sequenced with a mean target coverage greater than 50X (S2 Table). The remaining 9 Mb
of non-captured targets are uniformly absent across multiple samples indicating a systematic
failure of hybridization capture at these loci.
Global levels of DNA methylation
Contrary to prior reports and because our targets were not enriched for repetitive elements,
we did not observe a substantial decrease in overall methylation levels as a function of age. The
percentage of age-specific levels of methylation is approximately equivalent for spleen [42.97%
young vs. 43.23% aged] and brain [39.53% young vs. 37.10% aged].
Tissue-specific methylation differences
Separating methylated regions into subclasses [i.e. DMCs, regulatory elements, CpG islands,
shores and shelves] also shows no significant age-specific differences in overall DNA methyla-
tion levels. In contrast and as expected, when comparing the same subclasses between brain
and spleen, significant differences were noted in overall DNA methylation. When comparing
tissue-specific differences between spleen and brain independent of age, we identified 165,302
DMCs. These DMCs were predominantly located in non-CpG island and shore regions,
which were mostly located within intronic and intergenic regions (Fig 1).
Age-specific methylation differences
When examining differences between young and aged groups, we identified only a few thou-
sand loci that had significant differences in methylation (Fig 2). By examining the overlap
between brain and spleen at these loci, we identified 946 loci that were differentially methyl-
ated as a function of age independent of tissue. Of these, 529 were hypermethylated in aged
mice and the remaining 417 were hypomethylated. We found that [spleen and brain] age-spe-
cific DMCs were significantly more likely to be found in CpG island/shores and in exonic/pro-
moter regions of the genome compared to the tissue-specific DMCs [p = 0.024, one tailed t-
test]. The large number of tissue-specific, versus age-specific, DMCs is also driving the PCA
analysis and clustering dendrogram showing that, when clustering by methylation similarities,
samples cluster much more tightly as a function of tissue type rather than a function of age
(Fig 3, S1 Fig).
Validation using RRBS
Methylation calls from target capture were validated using the orthogonal platform, RRBS
[40]. Methylation calls within each group [young brain, aged brain, young spleen, aged spleen]
were compared against RRBS throughout the mouse genome. Looking at a range of 1,397–
3,266 sites we found on average a concordance of approximately ~75% [range 69.6%-76.9%]
Age-specific methylation
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Fig 1. Tissue-specific differentially methylated cytosines. The percent breakdown of locations for differentially methylated cytosines [DMCs]
as a function of tissue type between young brain and young spleen [left column], between old brain and old spleen [center column] and a pool
of all brain vs all spleen irrespective of age [N = 12 total in the right column]. The top row delineates between DMCs located at promoters,
exons, introns or intergenic regions. The bottom row delineates between DMCs located at CpG islands [CpGi], CpG shores or other regulatory
regions (see S1 Table).
https://doi.org/10.1371/journal.pone.0203147.g001
Fig 2. Age-specific differentially methylated cytosines. The percent breakdown of locations for differentially methylated regions [DMCs] as a
function of age between young and old brain [left column], between young and old spleen [center column] and an aggregate of all young versus
all old samples [N = 12 total in the right column]. The top row delineates between DMCs located at promoters, exons, introns or intergenic
regions. The bottom row delineates between DMCs located at CpG islands [CpGi], CpG shores or other regulatory regions (see S1 Table).
https://doi.org/10.1371/journal.pone.0203147.g002
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between the two different platforms. The strong concordance between methods suggested that
our sequencing results for these heterogeneous methylation signals were accurate.
Hypermethylated DMCs in aged mice
Bioinformatic analysis and visualization of the 529 hypermethylated DMCs on the Washing-
ton University Epigenome Browser allowed localization of age-specific DMCs. In aged mice,
we found a clustering of hypermethylated DMCs at exon 2 of the Slc11a2 [Dct] gene on chro-
mosome 14 (Fig 4), and at the transcription start sites of Sfi1 and Drg1. We also noted a pre-
ponderance of hypermethylation at binding sites for the pioneer factor Foxa2 and
transcription factor Esr1. There were 14 different regulatory sites for Foxa2 throughout the
genome that contained at least one hypermethylated DMC. One of these regulatory sites on
chromosome 11 [OREG1667474] showed 75 discreet sites of hypermethylation across 2.7 Mb
overlying the 5’ end of the Sfi1 open reading frame (Fig 5), which was also adjacent to two
other regulatory domains, OREG1756550 and OREG0042551. There were four such hyper-
methylated sites for Esr1 across chromosomes 6, 8, and 17. Of note, the hypermethylated
Foxa2 binding sites were primarily found on chromosome 11 as well as the hypermethylation
at Sfi1 and Drg1.
Hypomethylated DMCs in aged mice
DMCs with a significant lack of methylation in aged mice were observed clustered within a
2Mb regulatory regions on the X chromosome [OREG1829350 and OREG0052202] within
2,708 bp of each other, at the end of the Mid1 gene, as well as the transcription start site of
Isoc2b on chromosome 7. In addition to the hypermethylated regions described above, we
Fig 3. Dendrogram of individual tissue sample clustering based on patterns of CpG methylation. When clustering
the 12 samples by DMCs, the large number of tissue-specific versus age-specific DMCs is driving the principal
component analysis [S1 Fig] and this clustering dendrogram showing that, when clustering by methylation similarities,
samples cluster much more tightly as a function of tissue type rather than a function of age.
https://doi.org/10.1371/journal.pone.0203147.g003
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identified multiple hypomethylated regulatory regions for Foxa2 and Esr1 as well. The
OREG0052202 regulatory site on the X chromosome harbors 8 Foxa2 binding sites. There
were 13 additional regulatory sites across the genome for Foxa2 that showed at least one hypo-
methylated site. There were 8 regulatory regions for Esr1 with at least one hypomethylated
DMC. These were by far the most common TFBS associated with the DMCs we identified.
Discussion
Here, we implemented a genome-wide hybridization capture method to query large portions
of the murine methylome. We chose to use this hybridization strategy because it is more cost-
effective in terms of sequencing and computational analysis than whole genome bisulfite
sequencing, but is more comprehensive for regions of differential methylation than microar-
rays, which cannot offer single base resolution. Other methods such as MeDip-Seq, methyla-
tion-sensitive restriction enzymes [MSRE] and RRBS cannot be targeted, which limits their
utility.
In this study, we interrogated differences in DNA methylation as a function of age between
two murine tissues [brain and spleen] that have very different cellular proliferation rates and
are functionally/structurally diverse. Indeed, the spleen in particular has an important role as a
integral part of the immune system, and we have known for some time that both adaptive and
innate immune cells experience drastic functional alterations as a result of the aging process
[42–44]. Aging, then, represents a valuable window through which to capture changes that
have both physiologic and pathologic consequences, not just in the immune system but across
the body as well. Through this comparison, our goal was to identify regions of age-specific dif-
ferential methylation that were consistent between each tissue, suggesting a more universal
role in the aging process.
Unlike prior observations, we find no significant change in the overall global levels of age-
specific DNA methylation. We believe this difference is due to the fact that most prior studies
have used methylation survey methods that mainly focused on CpG islands and transposable
repetitive elements [e.g. Alu and L1][27,28]. The targeted methylome hybridization array
avoids repetitive element sequence as targets and integrates many genomic regions that are
Fig 4. Aged mouse-specific hypermethylation of exon 2 of Dct. An Epigenome Browser [http://epigenomegateway.
wustl.edu/] image of the cluster of differential methylation on chromosome 14 over exon 2 of the Dct gene between bases
118,442,000 and 118,443,000 [mm9]. Within the highlighted region, the specimens from old mice demonstrate an excess
of methylation [height of darker blue bars] compared to the young mice.
https://doi.org/10.1371/journal.pone.0203147.g004
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typically absent in arrays, MeDIP, RRBS or MSRE methods, which allows us to compare puta-
tive regulatory targets in greater detail.
While descriptive in nature, we identified an age-specific enrichment of differential methyl-
ation in binding sites for the transcription factors Foxa2 and Esr1, which are known to play
important roles in development and aging[33,45–48]. Foxa2 belongs to the family of forkhead
box transcription factors known to regulate multiple stages of mammalian life, beginning with
early development and continuing during organogenesis[45]. FoxA proteins are considered
‘pioneer factors’ that can engage silent chromatin and initiate a cascade of gene regulation, net-
works of subsequent transcription factors—so called batteries and terminal selector genes—
resulting in the precise specification of a given cell or tissue type[49]. Our results are consistent
with work showing that hypermethylation of Foxa2 promoters and binding sites corresponds
with premature and replicative senescence[50], hallmarks of disease-associated and physio-
logic aging, respectively. In contrast, Esr1 encodes the estrogen receptor-alpha (ERalpha] pro-
tein, which acts as a ligand-activated transcription factor. Age-specific hypermethylation of
ESR1 promoters and downstream effectors has been described in colon[35], prostate[48] and
hypothalamus[34]. There is additional evidence linking this receptor to the regulation of genes
previously known to be involved in aging such a: Ep300, Sp1, Src, Tff1, Ccnd1, Ncoa1, Ncoa2
and Ncoa3[34,47,51,52]. Strikingly, Carroll et al. demonstrated that 54% of estrogen receptor
binding regions also contain Forkhead factor binding sites and that FOXA1 co-binding was
necessary for ERalpha-mediated activation of estrogen receptor target genes on human chro-
mosomes 21 and 22 in MCF-7 breast cancer cells stimulated by estrogen[53]. Much of human
chromosome 22 is homologous to mouse chromosome 11, which contains the hypermethy-
lated regulatory sequences and genes in aged mice found in our survey. Mouse chromosome
11 has previously been implicated in premature death, infertility, runting and neurological
defects[54]. Nearby genes on chromosome 11 with hypermethylation at transcription start
sites were Sfi1, which is a spindle protein important for mitosis and organelle biogenesis[55]
and Drg1 [developmentally regulated GTP-binding protein 1], which is a highly conserved
gene important for development and regulating cell growth and acts as a tumor suppressor
Fig 5. Aged mouse-specific hypermethylation of Foxa2 binding sites at the transcription start site of Sfi1. An
Epigenome Browser image of the cluster of differential methylation on chromosome 11 over the transcription start site
of the Sfi1 gene between bases 3,092,600 [approximate] and 3,094,000 [mm9]. Within the highlighted region, the
specimens from old mice demonstrate an excess of methylation [height of darker blue bars] compared to the young
mice. This region contains several Foxa2 binding sites and is adjacent to three known regulatory domains:
OREG1667474, OREG1756550, and OREG0042551.
https://doi.org/10.1371/journal.pone.0203147.g005
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[56]. The specific hypermethylation of TSSs at these two genes could point to age-related tran-
scriptional repression of these two important genes involved in cell division and energy pro-
duction, respectively. The identification of a region of hypermethylation at exon 2 of the Dct
[Dopachrome tautomerase or Trp2] gene is more curious as this gene is well known for regula-
tion of melanin production and reactive oxygen species[57], but not associated with longevity.
However, it is an assumption that the gene[s] controlled by differential methylation are those
in closest proximity. In fact, FOXA1/ERalpha binding was shown to act on enhancers that
influenced expression of target genes as much as 100 kb away from the binding site[53], so the
downstream effects of these age-specific differentially methylated regions on mouse chromo-
somes 11 and X may be quite distant and far ranging. We also found discrete areas of age-
related hypomethylation on chromosome 7 at the transcription start site of Isoc2b, an isochor-
ismatase-like protein, and two sites on the X chromosome near the end of the Mid1 gene,
which encodes a microtubule-binding protein important for cell division, and whose overex-
pression has been implicated in the pathogenesis of Opitz syndrome[58]. Age-related hypo-
methylation of these sites could point to transcription-level increases in expression as part of
the aging process that could have physiologic and pathologic implications, which represents
an interesting avenue for future research. A limitation of our study is that we do not have cor-
relative gene expression data from our tissues or in public repositories as gene expression stud-
ies from mice aged>20 months is not common.
Conclusions
Using a novel murine hybridization capture array, we were able to characterize genome-wide
changes in DNA methylation as a function of both tissue type and age. By expanding our geno-
mic analysis beyond CpG islands and repetitive islands, we were able to accurately survey
global differences in methylation levels across the genome as well as discreet changes in indi-
vidual genomic areas. Our analysis showed that unlike previous reports, there was no signifi-
cant global decrease in methylation as a function of age. However, we were able to identify
discreet areas of tissue and age-dependent differential methylation. In particular, we were able
to identify areas of tissue-independent differential methylation in regions of the genome, both
coding and regulatory, associated with mechanisms of aging. In summary, these results suggest
that there are tissue-independent mechanisms of age-specific differential methylation that
influence specific transcription factor binding and subsequent gene regulation. These data will
facilitate hypothesis-driven research into the role of methylation on regulatory mechanisms
involved in healthy aging.
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